Development of Antisense Drugs for Dyslipidemia

Abnormal elevation of low-density lipoprotein (LDL) and triglyceride-rich lipoproteins in plasma as well as dysfunction of anti-atherogenic high-density lipoprotein (HDL) have both been recognized as essential components of the pathogenesis of atherosclerosis and are classified as dyslipidemia. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Tsuyoshi, Wada, Fumito, Harada-Shiba, Mariko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090806/
https://www.ncbi.nlm.nih.gov/pubmed/27466159
http://dx.doi.org/10.5551/jat.RV16001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090806/
https://www.ncbi.nlm.nih.gov/pubmed/27466159
http://dx.doi.org/10.5551/jat.RV16001

Ejemplares similares